Clinicopathological analysis and literature review of Burkitt-like lymphoma with 11q aberration
10.3760/cma.j.cn101721-20211208-000257
- VernacularTitle:伴有11号染色体长臂异常的Burkitt样淋巴瘤临床病理分析并文献复习
- Author:
Honglan ZHANG
1
;
Chunmei YANG
;
Congying YANG
;
Chunfang ZHANG
;
Yanhong NIE
;
Yanling HE
;
Qian WANG
;
Wanneng HE
;
Chang ZHANG
;
Hao CHEN
Author Information
1. 江苏省连云港市第一人民医院病理科，连云港 222000
- Keywords:
Lymphoma;
Chromosome 11q aberration;
MYC rearrangement;
Prognosis
- From:
Clinical Medicine of China
2022;38(3):222-227
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinicopathological features,differential diagnosis,treatment and prognosis of Burkitt-like lymphoma with 11q aberration (BLL-11q).Methods:The clinical manifestations,histological morphology,immunophenotype and molecular genetic changes of 2 cases of BLL-11q admitted to the department of pathology of The First People's Hospital of Lianyungang in 2020 and 2021 were analyzed retrospectively,and the relevant literatures were reviewed.Results:Patients were found with right neck masses inadvertently and grew rapidly. They presented with localized disease with Ann Arbor stages IA and IIA. Microscopically, the normal structure of the lymph node disappeared and was replaced by a diffuse proliferation of lymphocytes, with consistent morphology and medium size. And the presence of "star-sky" phenomenon was obvious, the morphological characteristics were similar to Burkitt lymphoma. Immunophenotypically, tumor cells were diffusely positive for CD20, CD79α, PAX5, CD10 and Bcl-6, partly moderately positive for C-MYC and MUM-1, however, CD3, Bcl-2, CD30 and TDT were negative,Ki-67 positive index was more than 95%, and EBER was negative. FISH detection showed that MYC, Bcl-2, and Bcl-6 were negative. Both cases had the 11q23.3 gain and 11q24.3 loss. Both patients were treated with chemotherapy and followed up for 10-22 months,and achieved complete remission and disease-free survival.Conclusion:BLL-11q is a rare germinal center B-cell lymphoma with abnormal long arm of chromosome 11 and lack of MYC gene rearrangement. It should be distinguished from Burkitt lymphoma, diffuse large B-cell lymphoma, B-lymphoblastic lymphoma, large B-cell lymphoma with IRF4 rearrangement and high-grade B-cell lymphoma. On the basis of morphology and immunophenotype, the diagnosis depends on genetic detection. There may be a better prognosis.
